Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDNF levels in ischemic stroke patients treated with rt-PA
NCT02860260Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Feb 2011
- Primary completion
- Jan 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Open-label trial of tissue-plasminogen activator in ischemic stroke, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoints: Plasma levels of Brain-Derived Neurotrophic Factor at Month 3 and Serum levels of Brain-Derived Neurotrophic Factor at Month 3. Started Feb 2011; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02860260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02860260.